This is the authors' abstract. We don't add key points for this paper.
A cyclopeptolide, a polyene, and an aminoreductone—species with completely different biogenetic origins—are the components of the antibiotically active natural product enopeptin B (1, see schematic representation below), which is particularly active against Staphylococcus aureus. The first total synthesis of this compound, which belongs to a new class of substances, was achieved by the clever use of the arsenal of methods available to modern peptide chemistry. The three basic units were coupled by two different routes.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: